We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
CNB Financial Corp
CCNE
$1.03B
| $611K | ﹤0.01% |
23,073
-291
| -1% | -$7.63K |
|
2427
Karyopharm Therapeutics
KPTI
$48M
| $609K | ﹤0.01% |
6,314
-99
| -2% | -$9.87K |
|
2428
Ocular Therapeutix
OCUL
$2.02B
| $607K | ﹤0.01% |
87,118
-1,844
| -2% | -$14.3K |
|
|
APR
2429
DELISTED
Apria, Inc. Common Stock
APR
| $605K | ﹤0.01% |
18,561
+4,632
| +33% | +$150K |
|
2430
Accel Entertainment
ACEL
$987M
| $604K | ﹤0.01% |
46,369
-2,673
| -5% | -$34K |
|
2431
Bank First Corp
BFC
$1.7B
| $604K | ﹤0.01% |
8,365
-114
| -1% | -$8.1K |
|
2432
Rhythm Pharmaceuticals
RYTM
$7.96B
| $604K | ﹤0.01% |
60,537
-750
| -1% | -$8.43K |
|
2433
Luxfer Holdings
LXFR
$458M
| $603K | ﹤0.01% |
31,251
-294
| -0.9% | -$5.98K |
|
2434
Southern First Bancshares
SFST
$600M
| $602K | ﹤0.01% |
9,635
-55
| -0.6% | -$3.23K |
|
|
PETQ
2435
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $602K | ﹤0.01% |
26,500
-464
| -2% | -$10.8K |
|
|
SCU
2436
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $598K | ﹤0.01% |
28,020
+109
| +0.4% | +$2.49K |
|
2437
The Honest Company
HNST
$586M
| $596K | ﹤0.01% |
73,664
+49,214
| +201% | +$433K |
|
2438
Corsair Gaming
CRSR
$1.55B
| $595K | ﹤0.01% |
28,307
+2,330
| +9% | +$55.7K |
|
|
REVG
2439
DELISTED
REV Group
REVG
| $595K | ﹤0.01% |
42,031
-39
| -0.1% | -$616 |
|
2440
Telos
TLS
$358M
| $595K | ﹤0.01% |
38,607
+1,932
| +5% | +$41.1K |
|
2441
PMV Pharmaceuticals
PMVP
$63.5M
| $594K | ﹤0.01% |
25,707
+896
| +4% | +$21.6K |
|
2442
Daily Journal
DJCO
$778M
| $593K | ﹤0.01% |
1,662
-12
| -0.7% | -$4.24K |
|
2443
NRC Health Common Stock
NRC
$450M
| $592K | ﹤0.01% |
14,258
-244
| -2% | -$10.6K |
|
|
CTT
2444
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $592K | ﹤0.01% |
67,945
-2,129
| -3% | -$19K |
|
2445
Stagwell
STGW
$2.24B
| $591K | ﹤0.01% |
68,153
-194
| -0.3% | -$1.67K |
|
2446
Ribbon Communications
RBBN
$383M
| $590K | ﹤0.01% |
97,518
-804
| -0.8% | -$4.77K |
|
|
YMAB
2447
DELISTED
Y-mAbs Therapeutics
YMAB
| $590K | ﹤0.01% |
36,417
-605
| -2% | -$12.9K |
|
|
MMAT
2448
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $589K | ﹤0.01% |
2,396
+307
| +15% | +$127K |
|
2449
MasterCraft Boat Holdings
MCFT
$590M
| $582K | ﹤0.01% |
20,545
+149
| +0.7% | +$4.07K |
|
|
TPIC
2450
DELISTED
TPI Composites
TPIC
| $582K | ﹤0.01% |
38,896
-106
| -0.3% | -$2.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.